| Prev Close | 101.59 |
| Open | 101.26 |
| Day Low/High | 100.20 / 105.44 |
| 52 Wk Low/High | 28.00 / 131.00 |
| Volume | 2.01M |
| Avg Volume | 1.76M |
BioNTech SE (BNTX)
103.50
1.90
1.90
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 228.60M |
| Market Cap | 15.85B |
| EPS | -0.90 |
| Div & Yield | N.A. (N.A) |
Latest News
Vaccinate Your Portfolio From the Hype
Let's look at the cold, hard facts around the vaccine rollout.
Season of the Witch, Indices Run Wild, Enter Moderna, FedEx Delivers
Plus, Coinbase files for an eventual initial public offering that should draw a ton of interest.
Vulnerable Markets, Rusty Staub, Narrowing Leadership, Trading AMD and Inseego
I fear our legislators see these statistics and misunderstand the plight of the lower to middle class American in this environment.
How I'm Playing Astra-Zeneca on Vaccine and Acquisition News
I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.
A Glance Behind, Sifting Through Events to Come, Waiting for Santa
Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).
Tough Jobs Stuff, Winter Economic Chill, Vaccine Hiccup, Disney Delights
Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.
How Confident Are Investors? Covid Vaccine Headway, DoorDash IPO, Trading Pfizer
There is little to no fear in the air, relative to what we as investors, and we as a people, have been through.
Covid Vaccine Distribution, Jobs, Stimulus Package, Brexit Terms, Investor Days
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
Real Money Post Industrial Average Climbs 9.5% Over November
The RMPIA also tops other indexes for year, shooting ahead 29%.
UK Okays Vaccine, Stimulus Stalls, Facebook's Digital Currency, Micron Guidance
Also, Salesforce posts successful quarter and announces Slack acquisition to effectively take on Microsoft.
Moderna Stock Is Outta Sight
I think I'll just forget to put a new price target on this name for a while. All of my prior sales were mistakes.
Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Big News Is Followed by Little Moves
A lot has happened over the past couple weeks, but little has changed. Let's dig in.
Broadening Market Performance, the Vaccine 'Put', Trading McKesson
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
3 Market Takeaways, Slowing Retail Sales, Nvidia Earnings, Tootsie Roll Squeeze
When Nvidia reports after the bell Wednesday, I'll be focused on three key things.
Here's How I'm Trading Moderna Right Now
I'm long MRNA and have been since the beginning of the pandemic.
Marketplace Uncertainties, Problematic Covid, Retailers' Earnings, Week Ahead
The only expectation that I have for now is a near certainty in increased volatility caused by several factors.
Come a Second Lockdown, Consider Shorting These 3 Sectors
Look at companies that were decimated by lockdowns in the spring and figure that history is about to repeat itself.
Are You Brave Enough to Invest in Energy-Related Stocks?
You had better ensure that your cash flow is improving owing to those holdings.
Indecisive Markets, RealClearPolitics, Infection Surge, Moderna, Disney Earnings
Trading volume was low enough Wednesday to indicate a lack of conviction, or conviction that did not spread across enough managers to truly change the narrative.
Let's Take a Look at Pfizer Partner BioNTech's Charts
Aggressive traders who have dug into the fundamentals of this German-based company could look to go long.
Vaccine Rotation, What I Bought and Sold, Stocks on Thin Ice, Apple's Event
What the Nasdaq experienced Monday is known not just as an 'Outside Day,' but an 'Outside Reversal,' and these can be dangerous.
Jim Cramer: Even With New Covid Weapon, the Fight Goes On
We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.
A Dose of Good News Spurs a 'Buy Everything' Rally
Here's how to position yourself now that news of the Pfizer vaccine has landed, and what's happening with the 'haves,' 'have nots' and Treasuries.
Pfizer's Ureka Moment and Why Winning Is Never Boring
The leaders now are suddenly the reopening stocks, while the work remotely and stay at home stocks are being sold.
I'm Long Moderna and Here's Why
The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.